Sino-Argi Leading Biosciences (603970) — Cash Flow-to-Debt Ratio
Sino-Argi Leading Biosciences (603970) has a Cash Flow-to-Debt Ratio of -0.08x as of September 2025, meaning its operating cash flow of CN¥-390.12 Million could theoretically repay 0% of its total liabilities (CN¥4.85 Billion) in one year. See how much free cash does Sino-Argi Leading Biosciences generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sino-Argi Leading Biosciences Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Sino-Argi Leading Biosciences across 14 annual periods. Also explore Sino-Argi Leading Biosciences (603970) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Sino-Argi Leading Biosciences (2012–2025)
Year-by-year debt coverage analysis for Sino-Argi Leading Biosciences. For market capitalisation and broader financial context, see Sino-Argi Leading Biosciences market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.02x | CN¥-78.31 Million | CN¥3.18 Billion | ▼ -131.4% |
| 2024 | 0.08x | CN¥307.40 Million | CN¥3.92 Billion | ▲ +137.6% |
| 2023 | -0.21x | CN¥-919.85 Million | CN¥4.41 Billion | ▼ -164.6% |
| 2022 | 0.32x | CN¥1.54 Billion | CN¥4.76 Billion | ▲ +243.1% |
| 2021 | 0.09x | CN¥325.42 Million | CN¥3.46 Billion | ▼ -23.1% |
| 2020 | 0.12x | CN¥352.12 Million | CN¥2.88 Billion | ▼ -5.3% |
| 2019 | 0.13x | CN¥218.90 Million | CN¥1.69 Billion | ▲ +220.0% |
| 2018 | 0.04x | CN¥65.69 Million | CN¥1.63 Billion | ▼ -85.1% |
| 2017 | 0.27x | CN¥518.83 Million | CN¥1.92 Billion | ▲ +282.4% |
| 2016 | 0.07x | CN¥152.22 Million | CN¥2.15 Billion | ▲ +160.5% |
| 2015 | -0.12x | CN¥-254.22 Million | CN¥2.17 Billion | ▼ -583.4% |
| 2014 | 0.02x | CN¥40.41 Million | CN¥1.67 Billion | ▲ +142.3% |
| 2013 | -0.06x | CN¥-79.66 Million | CN¥1.39 Billion | ▼ -151.9% |
| 2012 | 0.11x | CN¥109.43 Million | CN¥991.46 Million | — |